
Human Growth Hormone Market Facts, Future Scenarios, Growth and Analytical Insights

Rise in prevalence of menopausal disorder and surge in awareness about post-menopausal issues among women drive the growth of human growth hormone market.
PORTLAND, OREGON, UNITED STATES, December 17, 2021 /EINPresswire.com/ -- North America contributed to the highest share in terms of revenue in 2020, holding nearly half of the total market share, and is estimated to continue its dominant share by 2030. However, Asia-Pacific is projected to manifest the fastest CAGR of 10.2% during the forecast period. The hospital pharmacy segment held the largest market share in 2020, holding more than half of the total market share, and is expected to continue its leadership status during the forecast period. However, the online pharmacy segment is projected to register the highest CAGR of 10.2% from 2021 to 2030.
The turner syndrome segment held the highest market share in 2020 holding nearly one third of the total market share, and is expected to continue its leadership status during the forecast period. However, the growth hormone deficiency segment is estimated to register the highest CAGR of 10.1% from 2021 to 2030.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/5557
Leading players of the global human growth hormone market analyzed in the research include Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), Merck KGaA, Mylan N.V. (Viatris Inc.), Novartis International AG, Novo Nordisk A/S, and Pfizer Inc.
According to the report published by Allied Market Research, the global Human Growth Hormone Market generated $3.86 billion in 2020, and is projected to reach $9.21 billion by 2030, witnessing a CAGR of 9.0% from 2021 to 2030. Rise in prevalence of menopausal disorder, surge in awareness about post-menopausal issues among women, and increase in new launches by key players drive the growth of the global human growth hormone market. However, high cost of treatment and adverse effects of hormone replacement therapy restrain the market to some extent. On the other hand, alternatives of hormone replacement therapy and telemedicine for hormone replacement therapy present new opportunities in the upcoming years.
Explore More https://www.alliedmarketresearch.com/human-growth-hormone-market
Impact of COVID-19 on Human Growth Hormone Market :
• The outbreak of the COVID-19 pandemic has negatively impacted the hormone replacement therapy market.
• Fertility treatment and post menopause has been affected during the pandemic due to evidence suggesting that falling estrogen levels could leave older women at increased risk from the disease and possibility that hormone withdrawal may accelerate COVID-19 progression.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/5557
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
Similar Reports:
Medical Waste Management Market
Fundus Camera Market
Chromatography Market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Distribution channels: Healthcare & Pharmaceuticals Industry, Science
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release